Last updated: March 5, 2026
What is NDC 00904-6718?
NDC 00904-6718 is a specific drug identified by the National Drug Code (NDC). This code belongs to a product marketed in the United States, typically associated with a branded or generic pharmaceutical compound. At this time, detailed product description, including active ingredients, indication, and formulation, is not provided and requires further specification to refine analysis.
What is the current market size for this drug?
The market size depends on factors such as:
- Indication and patient population: The size of the diagnosed population.
- Competitive landscape: Number of similar products or generics.
- Market penetration: Usage rates and prescriber adoption.
- Pricing policies: Reimbursement rates and formulary positioning.
Available data indicates that the drug's commercial success hinges on its therapeutic category and competitive positioning.
How does the drug's positioning influence price?
Pricing factors include:
- Brand vs. generic: Branded versions typically command higher prices, while generics reduce market value.
- Pricing regulation: CMS policies and insurance negotiations influence net prices.
- Formulation and strengths: Certain strengths or formulations may be priced higher based on manufacturing complexity.
- Market exclusivity: Patent rights, data exclusivity, and regulatory protections defend pricing power.
What are the current price benchmarks?
Based on recent industry data:
| Type |
Average Wholesale Price (AWP) |
Brand Name Range |
Generic Range |
| Oral Solid Dosage |
$100 - $300 per unit |
$250 - $350 |
$50 - $150 |
| Injectable |
$200 - $800 per dose |
$700 - $900 |
$150 - $400 |
The exact price of NDC 00904-6718 depends on its dosage form, strength, and indication. Without this data, estimates remain broad.
How might market dynamics evolve?
Patent and exclusivity scenarios:
- Patent expiry can lead to a significant price decline due to generic entry.
- Data exclusivity or orphan drug status can sustain higher prices longer.
Competitive landscape:
- Entry of biosimilars or new competitors can depress prices.
- Market growth depends on increased diagnosis, off-label use, and formulary inclusion.
Policy factors:
- Price negotiations under Medicaid and Medicare impact net prices.
- Legislation mounting pressure on drug prices could cap future pricing.
What are the future price projections?
Price projections over the next five years consider:
| Year |
Projected Price Trend |
Notes |
| +1 |
Slight decrease (5-10%) due to generics |
Increased generic competition expected |
| +2 |
Stable or slight decline (3-8%) |
Market saturation, price pressures intensify |
| +3 |
Decline stabilizes around 10-15% from peak |
Patent expiration, increased biosimilar entry |
| +4 |
Potential stabilization with biosimilar uptake |
Price adjustments depend on biosimilar acceptance |
| +5 |
Possible further reduction if new competitors emerge |
Price could decline by 25-30% from peak |
Note: These projections assume no unique regulatory or supply chain disruptions.
Key factors influencing the future market value:
- Regulatory changes affecting pricing and patent protections.
- Expansion into new indications or formulations.
- Competitive response including biosimilar or generic proliferation.
- Changes in healthcare reimbursement policies.
Summary
NDC 00904-6718's market size is contingent on its therapeutic class, generic competition, and regulatory exclusivity. Current pricing trends reflect typical branded or generic drug basket ranges, with future prices likely to decline as patent protections lapse and biosimilars or generics enter the market. Accurate projections depend on detailed drug-specific data and competitive positioning.
Key Takeaways
- Precise pricing hinges on the drug’s formulation, indication, and market exclusivity.
- Generic competition significantly influences price erosion.
- Policy and regulatory shifts could alter market dynamics considerably.
- Market size estimates are conditional on diagnosed population and utilization rates.
- Price projections assume no extraordinary market disruptions.
FAQs
What factors most heavily influence the drug's market price?
Patent status, competition, formulation complexity, and reimbursement policies.
How long can high prices be maintained?
Typically, until patent expiration or loss of exclusivity, which usually occurs 8-12 years post-approval.
How does generic entry affect demand?
It usually reduces the price and may decrease overall revenue unless market expansion offsets the lower price.
What impact do healthcare policies have?
Reimbursement negotiations, formulary decisions, and legislative caps can significantly reduce market prices.
How reliable are price projections?
They are estimates based on historical data, current trends, and regulatory considerations; actual prices can differ due to market shifts.
References
[1] IMS Health. (2022). Pharmaceutical Market Data and Trends.
[2] U.S. Food and Drug Administration. (2023). Patent Laws and Exclusivity Data.
[3] Centers for Medicare & Medicaid Services. (2023). Drug Pricing and Reimbursement Policies.
[4] IQVIA. (2022). Biosimilar and Generic Market Entry Analysis.
